* If you want to update the article please login/register
"ROS1 is a proto-oncogene encoded a receptor tyrosine protein kinase, homologous to the v - Ros sequence of University of Manchester tumours virus 2 sarcoma virus, whose ligands are still being investigated. " Different types of tumors have been found with ROS1 fusion genes. ROS1 inhibitors are safe in patients with ROS1-positive NSCLC and are used for first-line clinical therapy, according to studies. This report contributes to our understanding of ROS1's biological characteristics, chemical advances and cancerous tumor cells, as well as future directions for creating ROS1 inhibitors with long-lived results. ".
Source link: https://europepmc.org/article/MED/35658765
"Gastric cancer is the fourth cause of cancer death globally, and gastric adenocarcinoma is the most common form. " The median survival rate for gastric cancer treatment has only increased by seven months. We investigated key pathways involved in gastric cancer development and analysis of potential drugs by systems biology and bioinformatics tools due to the relatively poor response of gastric cancer to surgery and adjuvant therapy, as well as the intricate role of risk factors in its outbreaks, including protein-pomp inhibitors and viral and bacterial infections. The underlying mechanisms were also reconstructed, with non-coding RNA versus coding RNA interference network and gene-disease network reconstructed to help identify the underlying mechanisms. Fostamatinib appears to be a potential therapeutic agent in gastric cancer due to its inhibitory role on two survival genes.
Source link: https://europepmc.org/article/MED/35650297
"The peritoneum is a common site of metastasis in advanced gastric cancer. " Diagnostic laparoscopy is now routinely performed as part of disease management, resulting in a new diagnosis of synchronous peritoneal metastasis. A combination of locoregional therapeutic techniques with systemic therapy is being trialed in Peritoneal-specific clinical trials. We summarize the latest findings of cancer biology, developments in surgical techniques, and the emergence of novel therapies as an integrated strategy emerges to promote GCPM as a distinct clinical entity in this review.
Source link: https://europepmc.org/article/MED/35649219
"Preclinical model systems are vital research tools that aid us in investigating the path of invasive lobular carcinoma of the breast. " This challenge is posed by the lower incidence of ILC, underrepresentation of patients with ILC in clinical trials, and intrinsic ILC tumor characteristics. All current in vitro and in vivo ILC preclinical models have their strengths and weaknesses, according to Weisser, and that, in addition to increasing ILC research, key deficiencies exist in each model context.
Source link: https://europepmc.org/article/MED/35276005
"One out of every eight women has breast cancer," says the author. We will specifically explore how the mevalonate pathway influences breast cancer biology in terms of promoting and modulating soluble and cellular pathways, as well as specific steps of tumor formation in this research. We'll also discuss the antitumor effects of the mevalonate pathway-inhibiting drugs, statins, and amino-bisphosphonates in breast cancer, as well as how they can be used for future precision therapy.
Source link: https://europepmc.org/article/MED/35640730
"Background Non-small cell lung cancer is estimated to account for more than 80% of all lung cancer cases, making it the world's leading cause of cancer-related deaths. " MicroRNA deregulation has been seen often in NSCLC, and has been traced to the disease's genesis, progression, and metastasis by altering their target genes. In NSCLC, our research concentrated on the function of down-regulated miRNAs. Materials and methods Our study was focused on the effectiveness of down-regulated miRNAs. We used 91 miRNAs found to be down-regulated in NSCLC for this research. These miRNAs were selected from miRNA databases with functionality in NSCLC, including miRBase, miRDB, miRTV, and others. In order to obtain physiologically relevant data about the target miR-520c-3p, experimentally, GSEA was used to examine 24607 genes published experimentally in order to obtain physiologically relevant data about the miR-520c-3p. MiR-520c-3p's presence in the PI3K/AKT/mTOR signaling pathway was recognized. Conclusions The therapeutic use of miR-520c-3p in a synthetic circuit was investigated, which may be helpful in suppressing tumors in NSCLC. ".
Source link: https://europepmc.org/article/MED/35634241
"The human body is endowed with the ability to maintain different oxygen levels in various tissues and organs. " In vitro experiments using normal and neoplastic cells require that culture conditions be carried out under controlled oxygen conditions, whether physoxic or hypoxic. Oncogenic pathway exacerbations were detected by deoxidizing agent pouches in Culturing cancer cells growing under atmospheric oxygen levels. We also observed elevated oxidative stress and superoxide levels, as well as increased cell cycle arrest, which was similar to the PI3K signaling disturbance. The cultivation of cancer stem cells in a time-dependent manner has resulted in the growth of cancer stem cells in a time-dependent manner, most interestingly. Overall, we have an easy-total cell culture kit in every wet lab equipped with cell culture equipment.
Source link: https://europepmc.org/article/MED/35628446
"Background" is a movie that illustrates that the mechanism of action for most cancer drugs is not clear. Using publicly available pharmacogenomic cancer cell line datas, we present a research plan for determining biological pathways that contribute to drug absorption. Methods We present a custom machine-learning based strategy for finding biological pathways involved in cancer drug reactions. We use our methodology to determine the determinants of drug resistance to microtubule inhibitors. Conclusions "Our findings show the value of combining informed feature selection and machine learning algorithms in understanding cancer drug responses. ".
Source link: https://europepmc.org/article/MED/35581546
"Colorectal cancer is the third most common cancer worldwide. " Despite the significant amount of work that has been put into the diagnosis and treatment of CRC, the overall survival rate of patients remains low. Accurate discovery of these genes and signaling pathways is a critical and urgent task for the next generation of anticancer therapy research. Protein family members of DnaJ/Hsp40 play both roles, increasing and reducing the growth of CRC cells. In the present study, we examine the latest research on the molecular mechanisms responsible for the role of DnaJ/Hsp40 in CRC carcinogenesis and biology.
Source link: https://europepmc.org/article/MED/35570564
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions